Concepedia

Cheng-Yao Lin

CL

7

Publications

228

Citations

7

H-Index

2001

Active since

Affiliations

Chi Mei Medical Center(Current)

National Cheng Kung University

Southern Taiwan University of Science and Technology

National Taiwan University Hospital

Bayer (United States)

Cheng-Yao Lin is an author at Chi Mei Medical Center specializing in medicine, radiation oncology, and oncology.

Top concepts

Publications per year

2001–2023

7

Publications

7

A Phase II Study of the Efficacy and Safety of the Combination Therapy of the MEK Inhibitor Refametinib (BAY 86-9766) Plus Sorafenib for Asian Patients with Unresectable Hepatocellular Carcinoma

Ho Yeong Lim, Jeong Heo, Hye Jin Choi et al. · Clinical Cancer Research · 2014 · 99 citations · Full text

QT interval effects of Cisapride in the clinical setting

Shuo Wang, Cheng-Yao Lin, Tzu‐Ling Huang et al. · International Journal of Cardiology · 2001 · 35 citations

, , +3

Diabetes mellitus impairs the response to intra-arterial chemotherapy in hepatocellular carcinoma

Yin‐Hsun Feng, Cheng-Yao Lin, Wen‐Tsung Huang et al. · Medical Oncology · 2010 · 24 citations

, , +12

Colorectal Cancer with EML4-ALK Fusion Gene Response to Alectinib: A Case Report and Review of the Literature

Sheng‐Yen Hsiao, Hong-Lin He, Teng-Song Weng et al. · Case Reports in Oncology · 2021 · 23 citations · Full text

, , +15

The model of descriptive, diagnostic, predictive, and prescriptive analytics on 100 top-cited articles of nasopharyngeal carcinoma from 2013 to 2022: Bibliometric analysis

Chung-Chia Hung, Mei-Yu Tu, Tsair‐Wei Chien et al. · Medicine · 2023 · 21 citations · Full text

Rows per page

1–5 of 7